Michael J. Vjecha

3.9k total citations · 1 hit paper
15 papers, 3.1k citations indexed

About

Michael J. Vjecha is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Michael J. Vjecha has authored 15 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 10 papers in Emergency Medicine and 7 papers in Virology. Recurrent topics in Michael J. Vjecha's work include HIV-related health complications and treatments (10 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). Michael J. Vjecha is often cited by papers focused on HIV-related health complications and treatments (10 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). Michael J. Vjecha collaborates with scholars based in United States, Australia and United Kingdom. Michael J. Vjecha's co-authors include Matthew Law, Sean Emery, Anthony D. Kelleher, Daniel D. Murray, Margaret Johnson, Jonel Trebicka, Kazuo Suzuki, Deborah Wentworth, Jens Lundgren and Andrew Phillips and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Michael J. Vjecha

15 papers receiving 3.1k citations

Hit Papers

Circulating microRNAs in Sera Correlate with Soluble Biom... 2015 2026 2018 2022 2015 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Vjecha United States 12 517 473 378 297 278 15 3.1k
Deborah Wentworth United States 10 560 1.1× 511 1.1× 380 1.0× 298 1.0× 452 1.6× 11 4.0k
Lynn E. Eberly United States 50 716 1.4× 470 1.0× 594 1.6× 375 1.3× 392 1.4× 221 7.5k
Daniel D. Murray Denmark 14 760 1.5× 199 0.4× 281 0.7× 300 1.0× 71 0.3× 35 3.1k
Jim Young Switzerland 32 471 0.9× 750 1.6× 727 1.9× 80 0.3× 306 1.1× 176 3.8k
David L. Graham United States 30 603 1.2× 203 0.4× 544 1.4× 204 0.7× 121 0.4× 95 3.0k
Sun Hee Lee South Korea 29 811 1.6× 488 1.0× 523 1.4× 68 0.2× 135 0.5× 208 3.5k
C.J. Duncan United Kingdom 39 1.3k 2.6× 556 1.2× 560 1.5× 554 1.9× 107 0.4× 215 5.6k
Martin Kidd South Africa 36 284 0.5× 1.2k 2.6× 1.4k 3.8× 424 1.4× 225 0.8× 226 4.9k
Tobias Sing Germany 18 1.2k 2.4× 706 1.5× 305 0.8× 409 1.4× 58 0.2× 30 3.6k
Mary M. Christopher United States 29 227 0.4× 182 0.4× 223 0.6× 222 0.7× 77 0.3× 130 2.7k

Countries citing papers authored by Michael J. Vjecha

Since Specialization
Citations

This map shows the geographic impact of Michael J. Vjecha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Vjecha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Vjecha more than expected).

Fields of papers citing papers by Michael J. Vjecha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Vjecha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Vjecha. The network helps show where Michael J. Vjecha may publish in the future.

Co-authorship network of co-authors of Michael J. Vjecha

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Vjecha. A scholar is included among the top collaborators of Michael J. Vjecha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Vjecha. Michael J. Vjecha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wright, Edwina, Birgit Grund, Kevin R. Robertson, et al.. (2018). No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. AIDS. 32(8). 985–997. 15 indexed citations
2.
Murray, Daniel D., Kazuo Suzuki, Matthew Law, et al.. (2017). Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals. Scientific Reports. 7(1). 10934–10934. 25 indexed citations
4.
Borges, Álvaro H., Jemma L. O’Connor, Andrew Phillips, et al.. (2016). Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection. The Journal of Infectious Diseases. 214(3). 408–416. 98 indexed citations
5.
Grarup, Jesper, et al.. (2016). Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials. Clinical Trials. 13(2). 127–136. 11 indexed citations
6.
Borges, Álvaro H., Jemma L. O’Connor, Andrew Phillips, et al.. (2015). Factors Associated With Plasma IL-6 Levels During HIV Infection. The Journal of Infectious Diseases. 212(4). 585–595. 127 indexed citations
7.
Murray, Daniel D., Kazuo Suzuki, Matthew Law, et al.. (2015). Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study. PLoS ONE. 10(10). e0139981–e0139981. 2528 indexed citations breakdown →
8.
Borges, Álvaro H., Jemma L. O’Connor, Andrew Phillips, et al.. (2014). Factors Associated with D-Dimer Levels in HIV-Infected Individuals. PLoS ONE. 9(3). e90978–e90978. 66 indexed citations
9.
Borges, Álvaro H., Jemma L. O’Connor, Andrew Phillips, et al.. (2014). Determinants of IL‐6 levels during HIV infection. Journal of the International AIDS Society. 17(4S3). 19482–19482. 8 indexed citations
10.
Grund, Birgit, Edwina Wright, Bruce J. Brew, et al.. (2013). Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. Journal of NeuroVirology. 19(4). 383–392. 9 indexed citations
11.
Achhra, Amit C., Janaki Amin, Matthew Law, et al.. (2010). Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS. 24(12). 1877–1886. 62 indexed citations
12.
Mocroft, Amanda, Alan R. Lifson, Giota Touloumi, et al.. (2010). Haemoglobin and Anaemia in the Smart Study. Antiviral Therapy. 16(3). 329–337. 13 indexed citations
13.
Hom, David L., John L. Johnson, Peter Mugyenyi, et al.. (1997). HIV-1 Risk and Vaccine Acceptability in the Ugandan Military. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(5). 375–380. 30 indexed citations
14.
Okwera, Alphonse, Joy L. Johnson, Michael J. Vjecha, et al.. (1997). Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.. PubMed. 1(5). 441–5. 9 indexed citations
15.
Okwera, Alphonse, Micheal Mugerwa, Jerrold J. Ellner, et al.. (1994). Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Lancet. 344(8933). 1323–1328. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026